Researchers at the University of Otago in New Zealand are recruiting for a novel trial, combining use of the drug ketami...
In a significant breakthrough, researchers from the Swiss Tropical and Public Health Institute (Swiss TPH) and...
Lion TCR has forged a strategic partnership with the National University of Singapore Guangzhou Research Translation and...
Researchers from the Institute for Functional Intelligent Materials (I-FIM) at the National University of Singapore (NUS...
US-based Charles River Laboratories International, Inc. and National University of Singapore’s (NUS) Yon...
The Biologics Pharma Innovation Programme Singapore (BioPIPS) consortium has strengthened its competencies by partnering...
The hidden epidemic of chronic wounds in Australia will be tackled through new initiatives funded with more than $3 mill...
Novartis is investing $256 million to expand its biopharmaceutical manufacturing plant in Singapore. The extended s...
Scientists from Duke-NUS Medical School (Duke-NUS) at Singapore have developed a new approach using the Zika virus to de...
Taiwan-based BioGate Precision Medicine Corp., a member of Powerchip Group, has unveiled an innovative breakthrough in p...
Epsilogen, a leading immunoglobulin E (IgE) antibodies developer treating cancer, and global biopharma leader Lonza have...
In a breakthrough for personalised oncology, scientists from the National University of Singapore (NUS) and the National...
A collaborative research team from the Department of Chemical Engineering and the School of Convergence Science and Tech...
Could you give us an overview of the GHIT Fund's mission and how it originated? The idea for the GHIT (Global Health In...
Orthohantaviruses, highly transmissible zoonotic pathogens, are notorious for causing haemorrhagic fever with renal synd...
As the world marks Cancer Awareness Month, Malaysia has made significant strides in the field of cancer treatment, earni...
Daiichi Sankyo, an innovative global healthcare company, has launched its subsidiary Daiichi Sankyo Singapore ...
China's AffaMed Therapeutics, has obtained New Drug Application (NDA) from Singapore Health Sciences Authority (HSA...
